People
Since Biogen and Tokyo-based Eisai recently reported a massive failure in Alzheimer’s research for their drug aducanumab, scientists and industry watchers are scanning the tea leaves looking for other potential approaches to treating the disease. One that is of interest is a hormone called Klotho.
Dr. Sarah Fakih joined MorphoSys AG as Vice President and Head of Corporate Communications and Investor Relations effective April 1, 2019.
Vancouver, British Columbia-- - NervGen Pharma Corp., a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, announced the appointment of Amy Franke as the Company’s Vice President, Clinical Operations.
Assertio Therapeutics, Inc. announced today that James J. Galeota, Jr. has been appointed to the Company’s Board of Directors.
Shares of Bristol-Myers Squibb are up slightly this morning after the proposed $74 billion acquisition of Celgene gained some significant support over the weekend. That support has caused at least one opposition group to withdraw from the fight.
During a presentation at the American Association for Cancer Research meeting over the weekend, Astellas touted new overall survival data for Xospata.
Biotech and pharma companies bring on new talent to strengthen leadership teams and boards.
South San Francisco-based Mission Bio, the only company providing single-cell DNA sequencing, entered into a collaboration with LabCorp, to harness the abilities of the company’s Tapestri Platform to provide more precise clinical trials.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The polar vortex that brought bone-chilling temperatures to much of the United States earlier this winter highlighted a near constant concern – an inadequate supply of platelets at blood centers across the country.
PRESS RELEASES